Learn more about Genomic Health's diagnostic tests, for breast and colon cancer, which can help patients and their doctors make better, more informed treament decisions.
Oncotype DX breast cancer test validated to predict local recurrence in patients with ductal carcinoma in situ DCIS, or pre-invasive breast cancer. Read more...
See how we are turning the promise of genomics into the practice of medicine. Includes a step-by-step "demo" of the Oncotype DX test process.
View a recent Bloomberg interview with CEO Kim Popovits and learn more about Genomic Health's perspective on genomics in cancer and current business highlights.
Genomic Health Announces Formation of New Genetics Subsidiary
Genomic Health Announces Year-End 2011 Financial Results, Provides 2012 Financial Outlook
